GeneDx Holdings Corp.
GeneDx Holdings Corp. scores highest on Earnings (53) and lowest on Price (9). Its PosiPenta is 38.32 out of 100, weaker than most similar companies.
On the Penta Grid this week, GeneDx Holdings Corp. is Grid #593 of 837 in the Healthcare sector in United States, and Grid #3,038 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| GeneDx Holdings Corp. | 38.32 | 9 | 53 | 42 | 40 | 49 |
| BioCryst Pharmaceuticals, Inc. | 56.90 | 0 | 65 | 65 | 98 | 56 |
| Xeris Biopharma Holdings, Inc. | 46.84 | 0 | 85 | 92 | 1 | 56 |
| Zymeworks Inc. | 45.90 | 3 | 60 | 79 | 40 | 47 |
| LeMaitre Vascular, Inc. | 57.12 | 37 | 59 | 52 | 60 | 78 |
| Alamar Biosciences, Inc. | 48.06 | 12 | 54 | 62 | 44 | 68 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -17.52 |
| P/B ratio | 7.77 |
EEarnings
| Trailing EPS | ₹-343.82 |
| Forward EPS | ₹113.52 |
NNitro
| Price | 6024.82 |
| 52-week high | 16183.94 |
| 52-week low | 3050.77 |
| Fall from 52-week high | 62.8% |
TTorque
| Return on equity (ROE) | -40.80% |
| Debt-to-equity | 0.69 |
AAnchor
| Beta (price swings) | 1.97 |
| Market cap | ₹17,967 Cr |
| Insider holding | 7.71% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is GeneDx Holdings Corp.'s PosiPenta score?
GeneDx Holdings Corp.'s PosiPenta is 38.32 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does GeneDx Holdings Corp. stand on the Penta Grid?
On the Penta Grid this week, GeneDx Holdings Corp. is Grid #593 of 837 in the Healthcare sector in United States, and Grid #3,038 of 4,000 in United States.
Which PosiPenta pillar is strongest for GeneDx Holdings Corp.?
Earnings (growth), with a score of 53 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for GeneDx Holdings Corp.?
Price (valuation), with a score of 9 out of 100: much weaker than most similar companies.
Has GeneDx Holdings Corp.'s PosiPenta changed since last week?
Yes, it rose 3.80 points, from 34.52 to 38.32.
PositoAI is for research and education only and is not investment advice.